LAZARD ASSET MANAGEMENT LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,452
+125.5%
38,538
+114.2%
0.01%
+150.0%
Q2 2023$1,531
-57.4%
17,988
-58.6%
0.00%
-60.0%
Q1 2023$3,593
+9.4%
43,429
+4.0%
0.01%0.0%
Q4 2022$3,285
-99.9%
41,771
-4.9%
0.01%0.0%
Q3 2022$3,253,000
+45.1%
43,944
+3.9%
0.01%
+150.0%
Q4 2021$2,242,000
+74633.3%
42,306
+89912.8%
0.00%
Q3 2021$3,0000.0%470.0%0.00%
Q2 2021$3,000
-99.9%
47
-99.9%
0.00%
-100.0%
Q1 2021$3,734,000
+7368.0%
33,645
+7853.9%
0.01%
Q4 2020$50,000
+38.9%
4230.0%0.00%
Q3 2020$36,000
+71.4%
423
+79.2%
0.00%
Q2 2020$21,000
-70.0%
236
-66.6%
0.00%
Q1 2020$70,000
-80.7%
706
-80.5%
0.00%
-100.0%
Q4 2018$362,000
+483.9%
3,623
+566.0%
0.00%
Q3 2018$62,000
-84.1%
544
-87.5%
0.00%
-100.0%
Q2 2018$390,000
-28.8%
4,353
-41.9%
0.00%0.0%
Q1 2018$548,000
+100.0%
7,493
+58.7%
0.00%
Q4 2017$274,000
-96.6%
4,721
-97.5%
0.00%
-100.0%
Q4 2013$8,057,000
-18.2%
191,256
-22.6%
0.02%
-21.7%
Q3 2013$9,855,000
-2.4%
247,125
+1.2%
0.02%
-4.2%
Q2 2013$10,100,000244,2630.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders